About this FactMed analysis covering adverse side effect reports of 5FU(FLUOROURACIL) patients who developed HICCUPS.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 1 individuals taking 5FU(FLUOROURACIL) reported HICCUPS to the FDA. A total of 1 5FU(FLUOROURACIL) drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between 5FU(FLUOROURACIL) and HICCUPS. In doing so, we compare 5FU(FLUOROURACIL) with other drugs that cause HICCUPS, to help you evaluate whether or not 5FU(FLUOROURACIL) causes HICCUPS. Likewise, this page shows the most highly-reported side effects of 5FU(FLUOROURACIL), so you can see if HICCUPS ranks among 5FU(FLUOROURACIL)'s most well-known side effects.
Summary Statistics
Reports of 5FU(FLUOROURACIL) causing HICCUPS: 1
Reports of any side effect of 5FU(FLUOROURACIL) : 1
Percentage of 5FU(FLUOROURACIL) patients where HICCUPS is a reported side effect: 100.0000%

FDA reports of any drug causing HICCUPS : 2364
Average percentage for all medicated patients where HICCUPS is reported as a complication: 0.0148%

Physician opinion on 5FU(FLUOROURACIL) as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing 5FU(FLUOROURACIL):
COLON CANCER ( 1 patients )
Drugs with high FDA adverse event association with HICCUPS:

COMMIT (324 patients)
ASPIRIN (194 patients)
NEXAVAR (175 patients)
NICORETTE (159 patients)
BYETTA (110 patients)
NEXIUM (102 patients)
OMEPRAZOLE (101 patients)
DEXAMETHASONE (94 patients)
FLUOROURACIL (84 patients)
CISPLATIN (80 patients)
LIPITOR (73 patients)
LASIX (64 patients)
DECADRON (64 patients)
ZOLOFT (63 patients)
NORVASC (63 patients)
FAMOTIDINE (63 patients)
ALLOPURINOL (59 patients)
PRILOSEC (57 patients)
VFEND (56 patients)
ABILIFY (55 patients)
PROTONIX (54 patients)
FORTEO (54 patients)
EMEND (54 patients)
AVASTIN (53 patients)
METOCLOPRAMIDE (53 patients)
MAGNESIUM OXIDE (53 patients)
METFORMIN HCL (52 patients)
NICORETTE (MINT) (52 patients)
OXYCONTIN (51 patients)
ATENOLOL (51 patients)
SUTENT (48 patients)
PREDNISONE (48 patients)
FOLIC ACID (48 patients)
REGLAN (46 patients)
ZOMETA (46 patients)
LISINOPRIL (45 patients)
AMLODIPINE (41 patients)
FENTANYL (40 patients)
IBUPROFEN (38 patients)
BACLOFEN (38 patients)
OXALIPLATIN (38 patients)
COUMADIN (37 patients)
SIMVASTATIN (37 patients)
ATIVAN (36 patients)
MORPHINE (35 patients)
SEROQUEL (35 patients)
LORAZEPAM (35 patients)
METHOTREXATE (34 patients)
ACETAMINOPHEN (34 patients)
NICOTINE POLACRILEX (34 patients)
VIOXX (34 patients)
DURAGESIC-100 (34 patients)
LEPONEX (34 patients)
CAPECITABINE (34 patients)
TOPROL-XL (34 patients)
DOXORUBICIN HCL (34 patients)
SORAFENIB (33 patients)
REVLIMID (33 patients)
KEPPRA (33 patients)
CLONAZEPAM (33 patients)
CRESTOR (33 patients)
MEGACE (33 patients)
VELCADE (32 patients)
MORPHINE SULFATE (32 patients)
COLACE (32 patients)
TAXOTERE (32 patients)
XANAX (32 patients)
CARBOPLATIN (32 patients)
ZOFRAN (32 patients)
TRENTAL ^ALBERT-ROUSSEL^ (32 patients)
LANSOPRAZOLE (31 patients)
VERSED (31 patients)
CLARITHROMYCIN (30 patients)
ADVAIR DISKUS 100/50 (30 patients)
DIOVAN (30 patients)
COMPAZINE (30 patients)
CHANTIX (30 patients)
HYDROCHLOROTHIAZIDE (30 patients)
ZITHROMAX (29 patients)
FUROSEMIDE (29 patients)
NICODERM CQ (29 patients)
LOTREL (29 patients)
PRADAXA (28 patients)
PAXIL (28 patients)
ARICEPT (28 patients)
DOXYCYCLINE (27 patients)
FLUCONAZOLE (27 patients)
GLYBURIDE (27 patients)
LEVOFLOXACIN (27 patients)
AMOXICILLIN (27 patients)
DEMEROL (27 patients)
DIAZEPAM (27 patients)
GEMZAR (27 patients)
GLEEVEC (27 patients)
PREVACID (26 patients)
VICTOZA (26 patients)
ACYCLOVIR (26 patients)
CYTARABINE (26 patients)
NEURONTIN (26 patients)
KYTRIL (26 patients)
TEMAZEPAM (26 patients)
LEVOTHYROXINE SODIUM (25 patients)
METOPROLOL TARTRATE (25 patients)
NYSTATIN (25 patients)
INSULIN (25 patients)
AMBIEN (25 patients)
LEUCOVORIN CALCIUM (25 patients)
LANTUS (25 patients)
HUMIRA (25 patients)
MIRALAX (24 patients)
PRIMPERAN TAB (24 patients)
LORTAB (24 patients)
XELODA (24 patients)
MICARDIS (23 patients)
FOSAMAX (23 patients)
ALBUTEROL (23 patients)
POTASSIUM CHLORIDE (23 patients)
METFORMIN HYDROCHLORIDE (22 patients)
ITRACONAZOLE (22 patients)
VICODIN (22 patients)
RANITIDINE (22 patients)
DILAUDID (22 patients)
GLUCOPHAGE (22 patients)
CYMBALTA (22 patients)
OXYCODONE HCL (22 patients)
ZYRTEC (21 patients)
ACETAMINOPHEN AND HYDROCODONE BITARTRATE (21 patients)
PANTOPRAZOLE (21 patients)
ACTOS (21 patients)
VALSARTAN (21 patients)
DEXAMETHASONE SODIUM PHOSPHATE (21 patients)
BEXTRA (21 patients)
DIGOXIN (20 patients)
GABAPENTIN (20 patients)
MEROPEN (20 patients)
IRESSA (20 patients)
PERCOCET (20 patients)
SPIRONOLACTONE (20 patients)
KEFLEX (20 patients)
AVONEX (20 patients)
ZANTAC (20 patients)
MUCODYNE (20 patients)
BENADRYL (20 patients)
TRAMADOL HCL (20 patients)
HYDROMORPHONE HCL (20 patients)
SINGULAIR (20 patients)
BIAXIN (20 patients)
BIAXIN XL (20 patients)
FLOMAX (20 patients)
SENOKOT (19 patients)
ZOCOR (19 patients)
MOBIC (19 patients)
AMARYL (19 patients)
AMLODIPINE BESYLATE (19 patients)
RISPERDAL (19 patients)
FLUITRAN (19 patients)
CYCLOPHOSPHAMIDE (19 patients)
M.V.I. (19 patients)
PROMETHAZINE (19 patients)
GLIPIZIDE (19 patients)
ENALAPRIL MALEATE (18 patients)
MULTI-VITAMIN (18 patients)
MARINOL (18 patients)
ALPRAZOLAM (18 patients)
VANCOMYCIN HYDROCHLORIDE (18 patients)
KETOCONAZOLE (18 patients)
NICOTINE (18 patients)
SENNA (18 patients)
LENDORMIN (18 patients)
MELOXICAM (18 patients)
INVANZ (18 patients)
LEVAQUIN (18 patients)
CYCLOSPORINE (17 patients)
PENTOXIFYLLINE (17 patients)
ALIMTA (17 patients)
CITALOPRAM HYDROBROMIDE (17 patients)
PHENERGAN (17 patients)
PLENDIL (17 patients)
URSODIOL (17 patients)
CIPROFLOXACIN (17 patients)
RADIATION THERAPY (17 patients)
FLAVERIC (17 patients)
HALOPERIDOL (16 patients)
URSO 250 (16 patients)
FLOXIN ^DAIICHI^ (16 patients)
PERIDEX (16 patients)
SYMBICORT (16 patients)
ZOLPIDEM TARTRATE (16 patients)
CEPHALEXIN (16 patients)
SULFAMETHOXAZOLE (16 patients)
ALDACTONE (16 patients)
PACLITAXEL (16 patients)
TYLENOL (CAPLET) (16 patients)
ORAMORPH SR (16 patients)
K-TAB (16 patients)
GENTAMICIN (16 patients)
TYSABRI (16 patients)
MULTI-VITAMINS (16 patients)
SODIUM CHLORIDE (16 patients)
SERTRALINE HCL (16 patients)
DIAMOX SRC (16 patients)
VIAGRA (16 patients)
DIANEAL (15 patients)
FLECTOR (15 patients)
AMANTADINE (15 patients)
PLACEBO (15 patients)
GEMCITABINE (15 patients)
DEXAMETHASONE TAB (15 patients)
METFORMIN (15 patients)
CLEOCIN (15 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for 5FU(FLUOROURACIL)


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about HICCUPS and 5FU(FLUOROURACIL), post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking 5FU(FLUOROURACIL), post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in 5FU(FLUOROURACIL). This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for 5FU(FLUOROURACIL) experts. If you are a healthcare provider experienced in prescribing 5FU(FLUOROURACIL), please register here.
giCould not connect: